Ileoduodenoplasty impact on foot purulent-necrotic lesion in type 2 diabetes patients

Authors

  • S. E. Podpryatov Kyiv City Center of Electric Welding Surgery Kyiv City Municipal Hospital No. 1
  • S. S. Podpriatov Kyiv City Center of Electric Welding Surgery Kyiv City Municipal Hospital No. 1
  • V. V. Salata Kyiv City Center of Electric Welding Surgery Kyiv City Municipal Hospital No. 1
  • V. V. Ivaha Kyiv City Center of Electric Welding Surgery Kyiv City Municipal Hospital No. 1
  • I. O. Bielousov Kyiv City Center of Electric Welding Surgery Kyiv City Municipal Hospital No. 1
  • V. P. Korchak Kyiv City Center of Electric Welding Surgery Kyiv City Municipal Hospital No. 1
  • I. V. Satsiuk Kyiv City Center of Electric Welding Surgery Kyiv City Municipal Hospital No. 1

DOI:

https://doi.org/10.11603/2414-4533.2019.1.9908

Keywords:

diabetes mellitus type II, ileoduodenoplasty, necrotic-purulent foot

Abstract

The aim of the work: to evaluate the effect of ileoduodenoplasty on the state of purulent necrosis of the foot in patients with diabetes mellitus type 2.

Materials and Methods. Twenty-one patients with type 2 diabetes complicated by purulent-necrotic lesions of the foot underwent a surgical intevention on intestine. Ileoduodenoplasty, the kind of duodenal elimination and ileum transposition, was performed. There were 12 men and 9 women at the median age 63 years, interquartile range (IQR) 13 years, with median body mass index (BMI) 32.3 kg/cm2, IQR 8.1 kg/cm2. Median diabetes duration was 10 years with IQR of 9 years. 6 patients received tablet glucose-lowering medicine, and 15 – received parenteral insulin injections.

Results and Discussion. Normoglycemia without medical correction was achieved three weeks after the ileoduodenoplasty was performed. 19 patients needed metformin intake during 2 months.

High amputation of the lower extremity was performed in 3 and 6 months after ileoduodenoplasty in 2 patients on the background of critical foot ischemia. In other patients foot arterial blood flow significantly improved. Patients with diabetic arthroseopathy and purulent foot defects did not have high amputation. In the term up to 5 years of neither hyperglycemia relapse, nor diabetic foot lesions were not observed.
Ileoduodenoplasty appears to be a more effective way of treating purulent-necrotic lesions of the foot in patients with type 2 diabetes mellitus compared with other methods.

References

Tchero, H., Kangambega, P., Noubou, L., Becsangele, B., Fluieraru, S., & Teot, L. (2018). Antibiotic therapy of diabetic foot infections: A systematic review of randomized controlled trials. Wound Repair Regen, 26 (5), 381-391. doi: 10.1111/wrr.12649.

Ammendola, M., Sacco, R., Butrico, L., Sammarco, G., de Franciscis, S., & Serra, R. (2017). The care of transmetatarsal amputation in diabetic foot gangrene. Int. Wound J., 14 (1), 9-15. doi: 10.1111/iwj.12682.

Borkosky, S.L., & Roukis, T.S. (2012). Incidence of re-amputation following partial first ray amputation associated with diabetes mellitus and peripheral sensory neuropathy: a systematic review. Diabet Foot Ankle, 3. doi: 10.3402/dfa.v3i0.12169.

Monteiro-Soares, M., Martins-Mendes, D., Vaz-Carneiro, A., Sampaio, S., & Dinis-Ribeiro, M. (2014). Classification systems for lower extremity amputation prediction in subjects with active diabetic foot ulcer: a systematic review and meta-analysis. Diabetes Metab. Res. Rev., 30 (7), 610-22. doi: 10.1002/dmrr.2535.

Peters, E.J., Lipsky, B.A., Aragón-Sánchez, J., Boyko, E.J., Diggle, M., Embil, J.M., … & Jeffcoate, W.J. (2016). International Working Group on the Diabetic Foot. Interventions in the management of infection in the foot in diabetes: a systematic review. Diabetes Metab. Res. Rev., 32, 1, 145-153. doi: 10.1002/dmrr.2706.

Dumville, J.C., Lipsky, B.A., Hoey, C., Cruciani, M., Fiscon, M., & Xia, J. (2017). Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database Syst. Rev., 14, 6, CD011038. doi: 10.1002/14651858.CD011038.pub2.

Selva Olid, A., Solà, I., Barajas-Nava, L.A., Gianneo, O.D., Bonfill Cosp, X., & Lipsky, B.A. (2015). Systemic antibiotics for treating diabetic foot infections. Cochrane Database Syst Rev, 4, (9), CD009061. doi: 10.1002/14651858.CD009061.pub2.

Lam, K., van Asten, S.A., Nguyen, T., La Fontaine, J., & Lavery, L.A. (2016). Diagnostic Accuracy of Probe to Bone to Detect Osteomyelitis in the Diabetic Foot: A Systematic Review. Clin. Infect. Dis., 1, 63 (7), 944-948. doi: 10.1093/cid/ciw445.

Treglia, G., Sadeghi, R., Annunziata, S., Zakavi, S.R., Caldarella, C., Muoio, B., … & Giovanella, L. (2013). Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography for the diagnosis of osteomyelitis related to diabetic foot: a systematic review and a meta-analysis. Foot (Edinb), 23 (4), 140-148. doi: 10.1016/j.foot.2013.07.002.

Andrews, K.L., Houdek, M.T., & Kiemele, L.J. (2015). Wound management of chronic diabetic foot ulcers: from the basics to regenerative medicine. Prosthet. Orthot. Int., 39 (1), 29-39. doi: 10.1177/0309364614534296.

Downloads

Published

2019-03-25

How to Cite

Podpryatov, S. E., Podpriatov, S. S., Salata, V. V., Ivaha, V. V., Bielousov, I. O., Korchak, V. P., & Satsiuk, I. V. (2019). Ileoduodenoplasty impact on foot purulent-necrotic lesion in type 2 diabetes patients. Hospital Surgery. Journal Named by L.Ya. Kovalchuk, (1), 25–30. https://doi.org/10.11603/2414-4533.2019.1.9908

Issue

No. 1 (2019)

Section

EXPERIMENTAL INVESTIGATIONS

License

Authors who publish their work in Hospital Surgery. Journal by L. Ya. Kovalchuk agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  
  2. Лицензия Creative Commons
  3. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)